Fabrizio Nerozzi

The discovery of GSK221149A: A potent and selective oxytocin antagonist

John Liddle, Michael Allen, Alan D. Borthwick et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency

Alan D. Borthwick, John Liddle, Dave E. Davies et al. · Journal of Medicinal Chemistry · 2012 · 89 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR

Paul G. Wyatt, Michael Allen, Alan D. Borthwick et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 66 citations

Medicine, Medicinal Chemistry, Pharmacology +9

2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics

Alan D. Borthwick, Dave E. Davies, Anne M. Exall et al. · Journal of Medicinal Chemistry · 2005 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Heterogeneous Catalytic Hydrogenation

Fabrizio Nerozzi · Platinum Metals Review · 2012 · 49 citations · Full text